SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04923126 |
|
Recruitment Status :
Recruiting
First Posted : June 11, 2021
Last Update Posted : April 17, 2024
|
Sponsor:
St. Jude Children's Research Hospital
Collaborator:
SpringWorks Therapeutics, Inc.
Information provided by (Responsible Party):
St. Jude Children's Research Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2031 |
| Estimated Study Completion Date : | June 2031 |